STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more

WorldPing

AstraZeneca stock fell as investors balked at reports of merger talks with Bristol Myers Squibb about forming one of ​the world's biggest drugmakers…

Related news

CNBC World•

AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed'

The companies have discussed a potential merger over several months, reports say.

Brief by WorldPing · Original reporting by CNBC World

WorldPing

The Guardian•

AstraZeneca holds talks with US cancer drug developer in $400bn merger

Bristol Myers Squibb tie-up would be one of biggest-ever pharma deals and create world’s fourth-largest drugmaker Business live – latest updates Britain’s biggest drugmaker, AstraZeneca, is understood to be in discussions to take over its US rival Br…

Brief by WorldPing · Original reporting by The Guardian

WorldPing

STAT•

STAT+: Is there a pharma mega-merger in the making?

Moderna's imminent FDA vaccine decision, TCGX launches $400M Asia biotech fund, and more biotech news…

Brief by WorldPing · Original reporting by STAT

WorldPing

CBS Sports•

Curt Cignetti talks like college football's alpha, but Indiana's schedule says otherwise

The reigning national champion Hoosiers are not scheduled to face a Power Four opponent or Notre Dame in non-conference until 2030…

Brief by WorldPing · Original reporting by CBS Sports

WorldPing

BBC News•

Iran says it is in talks with Oman but not the US after Trump says negotiations to resume

Tehran has repeatedly closed off the strait since the US and Israel attacked the country in February.

Brief by WorldPing · Original reporting by BBC News

CNBC World•

Trump says Iran talks to resume Monday after calling off planned strikes

The latest peace proposal calls for warring parties to return to negotiations and continue working out some of the thorny issues that derailed diplomatic efforts.

Brief by WorldPing · Original reporting by CNBC World